Access & Optionality: Expanding Patient Reach Through Integrated Companion Diagnostic & Laboratory-Developed Test (LDT) Strategies
- As precision medicine advances, CDx are increasingly essential, but are often perceived as a bottleneck to patient access
- Explore how an integrated approach can turn that challenge into an opportunity
- Learn how Quest BioPharma Services enables both CDx and LDT pathways under one roof, offering flexibility across the drug development and commercialization lifecycle